US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TRAWS PHARMA

1.47

-0.0100-0.68%

Volume:26.55K

Turnover:38.70K

Market Cap:8.18M

PE:-0.04

High:1.48

Open:1.46

Low:1.44

Close:1.48

Loading ...

Overview Company News Filings

Traws Pharma Inc - FDA Briefing Documents in Preparation for Discussion of Potential Accelerated Path to Approval

THOMSON REUTERS

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-Human Primates

THOMSON REUTERS

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates

BRIEF-Traws Pharma Presents Positive Data For TXM As Bird Flu Treatment At ICAR

Traws Pharma Inc - Presents Positive Data for Txm as Bird Flu Treatment at Icar

THOMSON REUTERS

Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR

BRIEF-Traws Pharma Enters $50 Million ATM Agreement With Citizens JMP Securities

Traws Pharma Inc - Enters $50 Million Atm Agreement With Citizens Jmp Securities

THOMSON REUTERS

Traws Pharma Reports Positive Results From an Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil

THOMSON REUTERS

Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil

BRIEF-Traws Pharma Reports Positive Results From Accepted Bird Flu Model For Anti-Viral Candidate, Tivoxavir Marboxil

Traws Pharma: Reports Positive Results From Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil

THOMSON REUTERS

Traws Pharma: Conducting Similar Challenge Study in Non-Human Primates, With Data Expected in Q1 2025

THOMSON REUTERS

Traws Pharma: Topline Data From Ferret Model Testing Show That Tivoxavir Marboxil Has Potential to Inhibit Disease After Bird Flu Infection

THOMSON REUTERS

Traws Pharma Regains Compliance With Nasdaq Equity Listing Rule

THOMSON REUTERS

Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule

BRIEF-Traws Pharma Names Nora Brennan Interim CFO

Traws Pharma Inc - on February 5, Mark Guerin Resigned as CFO of Traws Pharma

THOMSON REUTERS

BRIEF-Traws Pharma Announces Completion Of Phase I Studies With Tivoxavir Marboxil

Traws Pharma Announces Completion of Phase I Studies With Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5n1 Bird Flu

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TRAW/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAW\",,,,,undefined,":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":1.47,"timestamp":1751394217393,"preClose":1.48,"halted":0,"volume":26545,"delay":0,"floatShares":4196300,"shares":5564315,"eps":-35.21255,"marketStatus":"Trading","change":-0.01,"latestTime":"07-01 14:24:31 EDT","open":1.46,"high":1.48,"low":1.44,"amount":38700.889884000004,"amplitude":0.027027,"askPrice":1.48,"askSize":2,"bidPrice":1.44,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-35.21255,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1751400000000},"marketStatusCode":2,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":1.48,"preHourTrading":{"tag":"盘前","latestPrice":1.4701,"preClose":1.48,"latestTime":"09:13 EDT","volume":2387,"amount":3502.9418347,"timestamp":1751375604303},"postHourTrading":{"tag":"盘后","latestPrice":1.4201,"preClose":1.48,"latestTime":"19:50 EDT","volume":5770,"amount":8293.5567,"timestamp":1751327442830},"volumeRatio":0.265003,"impliedVol":1.6331,"impliedVolPercentile":0.9828},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAW\",,,,,undefined,":{"symbol":"TRAW","floatShares":4196300,"roa":"-83.59%","roe":"-2331.25%","lyrEps":-35.212551,"volumeRatio":0.265003,"shares":5564315,"dividePrice":0,"high":1.48,"amplitude":0.027027,"preClose":1.48,"low":1.44,"week52Low":0.97,"pbRate":"1.36","psRate":"36.03","week52High":19.44,"institutionHeld":0,"latestPrice":1.47,"committee":0.992032,"eps":-35.21255,"divideRate":0,"volume":26545,"delay":0,"ttmEps":-35.21255,"open":1.46,"prevYearClose":8.88,"prevWeekClose":1.43,"prevMonthClose":1.48,"prevQuarterClose":1.48,"fiveDayClose":1.53,"twentyDayClose":1.42,"sixtyDayClose":2.18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAW\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521746828","title":"Traws Pharma Inc - FDA Briefing Documents in Preparation for Discussion of Potential Accelerated Path to Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746828?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:01","pubTimestamp":1742814116,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q715T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2521450367","title":"Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-Human Primates","url":"https://stock-news.laohu8.com/highlight/detail?id=2521450367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521450367?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:01","pubTimestamp":1742814116,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q715T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2521746248","title":"Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746248","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746248?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two key measures of antiviral activity in preclinical bird ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/24/3047706/0/en/Traws-Pharma-Antiviral-Bird-Flu-Program-Tivoxavir-Marboxil-Shows-Positive-Data-in-Non-human-Primates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDC","BK4007","TRAW"],"gpt_icon":0},{"id":"2521404409","title":"BRIEF-Traws Pharma Presents Positive Data For TXM As Bird Flu Treatment At ICAR","url":"https://stock-news.laohu8.com/highlight/detail?id=2521404409","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521404409?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:03","pubTimestamp":1742554987,"startTime":"0","endTime":"0","summary":"BRIEF-Traws Pharma Presents Positive Data For TXM As Bird Flu Treatment At ICARMarch 21 (Reuters) - Traws Pharma Inc TRAW.O:TRAWS PHARMA INC - PRESENTS POSITIVE DATA FOR TXM AS BIRD FLU TREATMENT AT ICARSource text: ID:nGNX96RXJBFurther company coverage: TRAW.O ((Reuters.Briefs@thomsonreuters.com))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q4022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2521041274","title":"Traws Pharma Inc - Presents Positive Data for Txm as Bird Flu Treatment at Icar","url":"https://stock-news.laohu8.com/highlight/detail?id=2521041274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521041274?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:02","pubTimestamp":1742554927,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q4022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2521047884","title":"Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR","url":"https://stock-news.laohu8.com/highlight/detail?id=2521047884","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521047884?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:00","pubTimestamp":1742554800,"startTime":"0","endTime":"0","summary":"Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 data. “We were pleased to have the opportunity to share the promising TXM results in bird flu with the international antiviral community during the poster session at ICAR. We look forward to updating investors on Traws’ antiviral programs during a virtual event on Monday, March 31, 2025 at 10:00 AM ET, said Werner Cautreels, PhD, Chief Executive Officer of Traws Pharma.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/traws-pharma-bird-flu-drug-110000200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2518789849","title":"BRIEF-Traws Pharma Enters $50 Million ATM Agreement With Citizens JMP Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518789849?lang=en_us&edition=fundamental","pubTime":"2025-03-11 05:35","pubTimestamp":1741642539,"startTime":"0","endTime":"0","summary":"BRIEF-Traws Pharma Enters $50 Million ATM Agreement With Citizens JMP SecuritiesMarch 10 (Reuters) - Traws Pharma Inc TRAW.O:TRAWS PHARMA INC - ENTERS $50 MILLION ATM AGREEMENT WITH CITIZENS JMP SECURITIESFurther company coverage: TRAW.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2518678509","title":"Traws Pharma Inc - Enters $50 Million Atm Agreement With Citizens Jmp Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2518678509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518678509?lang=en_us&edition=fundamental","pubTime":"2025-03-11 05:13","pubTimestamp":1741641184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2516687580","title":"Traws Pharma Reports Positive Results From an Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil","url":"https://stock-news.laohu8.com/highlight/detail?id=2516687580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516687580?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA5QSSHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2516687768","title":"Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil","url":"https://stock-news.laohu8.com/highlight/detail?id=2516687768","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516687768?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"NEWTOWN, Pa., March  03, 2025  (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing oral small molecu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035447/0/en/Traws-Pharma-Reports-Positive-Results-from-An-Accepted-Bird-Flu-Model-for-Anti-Viral-Candidate-Tivoxavir-Marboxil.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CDC","TRAW"],"gpt_icon":0},{"id":"2516684649","title":"BRIEF-Traws Pharma Reports Positive Results From Accepted Bird Flu Model For Anti-Viral Candidate, Tivoxavir Marboxil","url":"https://stock-news.laohu8.com/highlight/detail?id=2516684649","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516684649?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:18","pubTimestamp":1741000710,"startTime":"0","endTime":"0","summary":"BRIEF-Traws Pharma Reports Positive Results From Accepted Bird Flu Model For Anti-Viral Candidate, Tivoxavir MarboxilMarch 3  - Traws Pharma TRAW.O:TRAWS PHARMA: REPORTS POSITIVE RESULTS FROM ACCEPTED BIRD FLU MODEL FOR ANTI-VIRAL CANDIDATE, TIVOXAVIR MARBOXILTRAWS PHARMA: TOPLINE DATA FROM FERRET MODEL TESTING SHOW THAT TIVOXAVIR MARBOXIL HAS POTENTIAL TO INHIBIT DISEASE AFTER BIRD FLU INFECTIONTRAWS PHARMA: CONDUCTING SIMILAR CHALLENGE STUDY IN NON-HUMAN PRIMATES, WITH DATA EXPECTED IN Q1 2025Source text: [ID:]Further company coverage: TRAW.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM024:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2516681758","title":"Traws Pharma: Reports Positive Results From Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil","url":"https://stock-news.laohu8.com/highlight/detail?id=2516681758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516681758?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:06","pubTimestamp":1741000005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM024:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2516681713","title":"Traws Pharma: Conducting Similar Challenge Study in Non-Human Primates, With Data Expected in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516681713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516681713?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:06","pubTimestamp":1741000005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM024:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2516068173","title":"Traws Pharma: Topline Data From Ferret Model Testing Show That Tivoxavir Marboxil Has Potential to Inhibit Disease After Bird Flu Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2516068173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516068173?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:06","pubTimestamp":1741000005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM024:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2514532803","title":"Traws Pharma Regains Compliance With Nasdaq Equity Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2514532803","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514532803?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA5K9HDM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2514913323","title":"Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2514913323","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514913323?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744000,"startTime":"0","endTime":"0","summary":"NEWTOWN, Pa., Feb. 28, 2025  -- Traws Pharma, Inc.  , a clinical stage biopharmaceutical company developing oral small molecules for the treatment of respiratory viral diseases, announced today that it has received confirmation from Nasdaq that Traws has regained compliance with the minimum stockholders’ equity requirements of Nasdaq Listing Rule 5550, which requires listed companies to maintain a minimum of $2.5 million in stockholders’ equity. Accordingly, Traws common stock will continue to be listed and trade on The NASDAQ Capital Market under the symbol “TRAW”.Traws is committed to delivering novel compounds for unmet medical needs using state-of-t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/traws-pharma-regains-compliance-nasdaq-120000952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","TQQQ","BK4112","LU2210150020.SGD","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD",".IXIC","USAW.SI","BK4007","USJW.SI","NVIW.SI","BK4585","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","PSQ","EQR","TRAW","NDAQ","IE00B3QW5Z07.USD","QID","TSYW.SI","MNQmain","QLD","SQQQ","NQmain"],"gpt_icon":1},{"id":"2509774503","title":"BRIEF-Traws Pharma Names Nora Brennan Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774503","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509774503?lang=en_us&edition=fundamental","pubTime":"2025-02-08 05:43","pubTimestamp":1738964613,"startTime":"0","endTime":"0","summary":"BRIEF-Traws Pharma Names Nora Brennan Interim CFOFeb 7  - Traws Pharma Inc TRAW.O:TRAWS PHARMA INC - ON FEBRUARY 5, MARK GUERIN RESIGNED AS CFO OF TRAWS PHARMATRAWS PHARMA INC - NORA BRENNAN APPOINTED INTERIM CFO OF TRAWS PHARMASource text: [ID:n0001104659-25-010580]Further company coverage: TRAW.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nFWN3OY12O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2509264771","title":"Traws Pharma Inc - on February 5, Mark Guerin Resigned as CFO of Traws Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2509264771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509264771?lang=en_us&edition=fundamental","pubTime":"2025-02-08 05:32","pubTimestamp":1738963922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nFWN3OY12O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2505094905","title":"BRIEF-Traws Pharma Announces Completion Of Phase I Studies With Tivoxavir Marboxil","url":"https://stock-news.laohu8.com/highlight/detail?id=2505094905","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505094905?lang=en_us&edition=fundamental","pubTime":"2025-01-23 20:14","pubTimestamp":1737634466,"startTime":"0","endTime":"0","summary":"BRIEF-Traws Pharma Announces Completion Of Phase I Studies With Tivoxavir MarboxilJan 23 (Reuters) - Traws Pharma Inc TRAW.O:TRAWS PHARMA ANNOUNCES COMPLETION OF PHASE I STUDIES WITH TIVOXAVIR MARBOXI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250123:nTUA33LX2X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2505161091","title":"Traws Pharma Announces Completion of Phase I Studies With Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5n1 Bird Flu","url":"https://stock-news.laohu8.com/highlight/detail?id=2505161091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505161091?lang=en_us&edition=fundamental","pubTime":"2025-01-23 20:00","pubTimestamp":1737633603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250123:nTUA33LX2X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"TRAW","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":2.09},{"market":"US","date":"2025-03-31","symbol":"TRAW","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":95.66},{"market":"US","date":"2024-11-14","symbol":"TRAW","fiscalQuarterEnding":"2024/09","expectedEps":-6.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-8.81},{"market":"US","date":"2024-09-23","symbol":"TRAW","defaultRemindTime":1727098200000,"type":"split","dateTimestamp":1727064000000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2024-08-15","symbol":"TRAW","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723694400000,"reportTimeType":"pre","actualEps":-4.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAW","date":"2025-06-30","current":-0.056815,"percent":0.868966,"low":-0.930105,"twenty":-0.557274,"median":-0.103725,"eighty":-0.062794,"high":-0.033516,"avg":-0.246968,"sd":0.274787,"marketCap":7956970},"quantilePoints":[{"date":"2024-04-05","current":-0.930105,"twenty":-0.930105,"median":-0.930105,"eighty":-0.930105,"marketCap":17623624},{"date":"2024-04-12","current":-0.875242,"twenty":-0.899279,"median":-0.879971,"eighty":-0.87246,"marketCap":16584087},{"date":"2024-04-19","current":-0.774197,"twenty":-0.884701,"median":-0.859217,"eighty":-0.774642,"marketCap":14669484},{"date":"2024-04-26","current":-0.703922,"twenty":-0.875242,"median":-0.784323,"eighty":-0.745597,"marketCap":13337908},{"date":"2024-05-03","current":-0.713993,"twenty":-0.87246,"median":-0.75973,"eighty":-0.713993,"marketCap":13528735},{"date":"2024-05-10","current":-0.722239,"twenty":-0.859217,"median":-0.743093,"eighty":-0.71377,"marketCap":13684982},{"date":"2024-05-17","current":-0.7463,"twenty":-0.799236,"median":-0.738475,"eighty":-0.713993,"marketCap":13549821},{"date":"2024-05-24","current":-0.73457,"twenty":-0.794005,"median":-0.741761,"eighty":-0.718444,"marketCap":13336853},{"date":"2024-05-31","current":-0.675921,"twenty":-0.778515,"median":-0.736522,"eighty":-0.713681,"marketCap":12272014},{"date":"2024-06-07","current":-0.836261,"twenty":-0.794624,"median":-0.73457,"eighty":-0.711322,"marketCap":15183160},{"date":"2024-06-14","current":-0.873049,"twenty":-0.83888,"median":-0.740589,"eighty":-0.71288,"marketCap":15851082},{"date":"2024-06-21","current":-0.649387,"twenty":-0.836845,"median":-0.738475,"eighty":-0.709541,"marketCap":11790270},{"date":"2024-06-28","current":-0.62709,"twenty":-0.83835,"median":-0.738475,"eighty":-0.706993,"marketCap":11385454},{"date":"2024-07-05","current":-0.557395,"twenty":-0.836651,"median":-0.734469,"eighty":-0.698614,"marketCap":10120072},{"date":"2024-07-12","current":-0.483661,"twenty":-0.814046,"median":-0.728873,"eighty":-0.672205,"marketCap":8781358},{"date":"2024-07-15","current":-0.554747,"twenty":-0.806641,"median":-0.726171,"eighty":-0.663181,"marketCap":10071990},{"date":"2024-08-02","current":-0.532446,"twenty":-0.799236,"median":-0.724978,"eighty":-0.649387,"marketCap":9667086},{"date":"2024-08-09","current":-0.491259,"twenty":-0.797102,"median":-0.722239,"eighty":-0.600613,"marketCap":8919304},{"date":"2024-08-16","current":-0.066488,"twenty":-0.794005,"median":-0.718444,"eighty":-0.532446,"marketCap":9112137},{"date":"2024-08-23","current":-0.065565,"twenty":-0.774642,"median":-0.71377,"eighty":-0.508851,"marketCap":8985580},{"date":"2024-08-30","current":-0.06743,"twenty":-0.774197,"median":-0.709986,"eighty":-0.494812,"marketCap":9241226},{"date":"2024-09-06","current":-0.06538,"twenty":-0.762623,"median":-0.702951,"eighty":-0.490604,"marketCap":8960268},{"date":"2024-09-13","current":-0.062794,"twenty":-0.758648,"median":-0.694503,"eighty":-0.071087,"marketCap":8605907},{"date":"2024-09-20","current":-0.057254,"twenty":-0.751084,"median":-0.683063,"eighty":-0.068232,"marketCap":7846562},{"date":"2024-09-27","current":-0.081301,"twenty":-0.74722,"median":-0.649387,"eighty":-0.067774,"marketCap":11142278},{"date":"2024-10-04","current":-0.073971,"twenty":-0.746382,"median":-0.624791,"eighty":-0.068232,"marketCap":10137646},{"date":"2024-10-11","current":-0.065174,"twenty":-0.745738,"median":-0.557395,"eighty":-0.067596,"marketCap":8932088},{"date":"2024-10-18","current":-0.062642,"twenty":-0.744673,"median":-0.543597,"eighty":-0.067316,"marketCap":8585034},{"date":"2024-10-25","current":-0.111702,"twenty":-0.743234,"median":-0.515682,"eighty":-0.066488,"marketCap":15308680},{"date":"2024-10-31","current":-0.109715,"twenty":-0.741526,"median":-0.508851,"eighty":-0.066652,"marketCap":15036392},{"date":"2024-11-08","current":-0.111592,"twenty":-0.739321,"median":-0.498158,"eighty":-0.06682,"marketCap":15293553},{"date":"2024-11-15","current":-0.123204,"twenty":-0.736132,"median":-0.492107,"eighty":-0.067201,"marketCap":16884930},{"date":"2024-11-22","current":-0.096923,"twenty":-0.734509,"median":-0.489621,"eighty":-0.06743,"marketCap":13645248},{"date":"2024-11-29","current":-0.098427,"twenty":-0.734469,"median":-0.48099,"eighty":-0.067496,"marketCap":13857037},{"date":"2024-12-06","current":-0.108407,"twenty":-0.733312,"median":-0.130241,"eighty":-0.067596,"marketCap":15262104},{"date":"2024-12-13","current":-0.104014,"twenty":-0.729414,"median":-0.121316,"eighty":-0.067685,"marketCap":14643681},{"date":"2024-12-20","current":-0.114642,"twenty":-0.725217,"median":-0.114642,"eighty":-0.068025,"marketCap":16139817},{"date":"2024-12-27","current":-0.244993,"twenty":-0.723719,"median":-0.117501,"eighty":-0.068353,"marketCap":34491315},{"date":"2025-01-03","current":-0.186323,"twenty":-0.723452,"median":-0.123204,"eighty":-0.068427,"marketCap":26231553},{"date":"2025-01-10","current":-0.173429,"twenty":-0.722482,"median":-0.130241,"eighty":-0.069344,"marketCap":24416220},{"date":"2025-01-17","current":-0.146996,"twenty":-0.721141,"median":-0.147157,"eighty":-0.069786,"marketCap":20694789},{"date":"2025-01-24","current":-0.13797,"twenty":-0.719413,"median":-0.140763,"eighty":-0.070056,"marketCap":19424056},{"date":"2025-01-31","current":-0.156666,"twenty":-0.718444,"median":-0.146996,"eighty":-0.070643,"marketCap":22056288},{"date":"2025-02-07","current":-0.178157,"twenty":-0.715773,"median":-0.153981,"eighty":-0.07105,"marketCap":25081842},{"date":"2025-02-14","current":-0.173739,"twenty":-0.713859,"median":-0.157526,"eighty":-0.072709,"marketCap":24459897},{"date":"2025-02-21","current":-0.121618,"twenty":-0.713592,"median":-0.156666,"eighty":-0.073848,"marketCap":17121928},{"date":"2025-02-28","current":-0.087129,"twenty":-0.71288,"median":-0.149414,"eighty":-0.074131,"marketCap":12266456},{"date":"2025-03-07","current":-0.070533,"twenty":-0.710432,"median":-0.144632,"eighty":-0.071013,"marketCap":9929988},{"date":"2025-03-14","current":-0.07157,"twenty":-0.706225,"median":-0.135069,"eighty":-0.071013,"marketCap":10076017},{"date":"2025-03-21","current":-0.074682,"twenty":-0.703145,"median":-0.130241,"eighty":-0.070984,"marketCap":10514105},{"date":"2025-03-28","current":-0.066643,"twenty":-0.70173,"median":-0.123448,"eighty":-0.070533,"marketCap":9382378},{"date":"2025-04-04","current":-0.066422,"twenty":-0.698614,"median":-0.121618,"eighty":-0.069679,"marketCap":11060862},{"date":"2025-04-11","current":-0.053321,"twenty":-0.692996,"median":-0.117957,"eighty":-0.068372,"marketCap":8879132},{"date":"2025-04-17","current":-0.060633,"twenty":-0.690629,"median":-0.115407,"eighty":-0.067596,"marketCap":10096842},{"date":"2025-04-25","current":-0.046618,"twenty":-0.687348,"median":-0.111751,"eighty":-0.066971,"marketCap":7762898},{"date":"2025-05-02","current":-0.042961,"twenty":-0.674063,"median":-0.111618,"eighty":-0.066488,"marketCap":7154043},{"date":"2025-05-09","current":-0.042657,"twenty":-0.663181,"median":-0.111481,"eighty":-0.065417,"marketCap":7103306},{"date":"2025-05-16","current":-0.033516,"twenty":-0.647743,"median":-0.11053,"eighty":-0.064788,"marketCap":5581169},{"date":"2025-05-23","current":-0.045648,"twenty":-0.63835,"median":-0.110157,"eighty":-0.064588,"marketCap":6392975},{"date":"2025-05-30","current":-0.055226,"twenty":-0.62709,"median":-0.109384,"eighty":-0.063348,"marketCap":7734397},{"date":"2025-06-06","current":-0.058802,"twenty":-0.622492,"median":-0.108696,"eighty":-0.062794,"marketCap":8235186},{"date":"2025-06-13","current":-0.071516,"twenty":-0.600613,"median":-0.107668,"eighty":-0.063175,"marketCap":10015767},{"date":"2025-06-20","current":-0.065556,"twenty":-0.566039,"median":-0.107023,"eighty":-0.063313,"marketCap":9181119},{"date":"2025-06-27","current":-0.056815,"twenty":-0.557298,"median":-0.10387,"eighty":-0.062794,"marketCap":7956970},{"date":"2025-06-30","current":-0.056815,"twenty":-0.557274,"median":-0.103725,"eighty":-0.062794,"marketCap":7956970}],"updateTime":1751394271668}}}